more is needed for immunotherapy in lung cancer
Published 4 years ago • 76 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
1:00:44
practical application of recent clinical data for immunotherapy in nsclc
-
5:25
immunotherapy in lung cancer
-
0:48
immunotherapy for patients with small-cell lung cancer
-
4:41
immunotherapy for operable nsclc
-
6:40
chemotherapy/immunotherapy combinations in lung cancer
-
9:57
practical considerations for immunotherapy in stage 3 nsclc
-
5:43
duration of upfront immunotherapy for nsclc
-
0:56
dr. papadimitrakopoulou on role of immunotherapy in lung cancer
-
6:36
patient selection for upfront immunotherapy in nsclc - o
-
5:22
treatment for nsclc after progression on immunotherapy
-
3:46
understanding immunotherapy for lung cancer
-
4:02
immunotherapy options for lung cancer variations
-
2:47
current status of immunotherapy in lung cancer
-
5:00
implications for pembrolizumab in nsclc
-
5:27
combined immunotherapy and chemotherapy for nsclc
-
1:00
dr. papadimitrakopoulou provides an update on pembrolizumab for lung cancer
-
1:36
dr. rudin on expansion of immunotherapy in lung cancer
-
2:30
dr. garon on concerns for immunotherapy combinations in lung cancer
-
1:48
dr. mark kris on immunotherapy and frontline options for patients with nsclc